APA (7th ed.) Citation

VS, K., BG, S., KK, M., ML, K., KM, M., M, M., . . . R, K. (2025). Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: A phase I study with immunological correlates. Nature communications, 16(1), 8696. https://doi.org/10.1038/s41467-025-63718-2

Chicago Style (17th ed.) Citation

VS, Kalluri, et al. "Engineered Exosomes with KrasG12D Specific SiRNA in Pancreatic Cancer: A Phase I Study with Immunological Correlates." Nature Communications 16, no. 1 (2025): 8696. https://doi.org/10.1038/s41467-025-63718-2.

MLA (9th ed.) Citation

VS, Kalluri, et al. "Engineered Exosomes with KrasG12D Specific SiRNA in Pancreatic Cancer: A Phase I Study with Immunological Correlates." Nature Communications, vol. 16, no. 1, 2025, p. 8696, https://doi.org/10.1038/s41467-025-63718-2.